Page last updated: 2024-08-21

treosulfan and Primary Immunodeficiency Diseases

treosulfan has been researched along with Primary Immunodeficiency Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Arranto, C; Dalla Via, V; Heim, D; Junker, T; Matteazzi, F; Medinger, M; Passweg, JR; Recher, M; Stelmes, A; van den Berg, J1
Gennery, AR; Hoenig, M; Lum, SH; Slatter, MA1

Reviews

1 review(s) available for treosulfan and Primary Immunodeficiency Diseases

ArticleYear
Conditioning Regimens for Hematopoietic Cell Transplantation in Primary Immunodeficiency.
    Current allergy and asthma reports, 2019, 11-18, Volume: 19, Issue:11

    Topics: Busulfan; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Primary Immunodeficiency Diseases; Transplantation Conditioning; Vidarabine

2019

Other Studies

1 other study(ies) available for treosulfan and Primary Immunodeficiency Diseases

ArticleYear
Treosulfan-based Reduced-intensity Allogeneic Hematopoietic Cell Transplantation in Adults With Primary Immunodeficiency: A Case Series.
    Anticancer research, 2022, Volume: 42, Issue:9

    Topics: Adult; Busulfan; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Primary Immunodeficiency Diseases

2022